BNTA
CAS No. 685119-25-9
BNTA ( —— )
产品货号. M35227 CAS No. 685119-25-9
BNTA 是一种有效的细胞外基质 (ECM) 调节剂,通过激活超氧化物歧化酶 3 (SOD3) 促进软骨细胞上软骨结构分子的合成。BNTA 通过调节软骨生成显示了一种有希望的缓解骨关节炎的潜力。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1085 | 有现货 |
|
| 5MG | ¥1599 | 有现货 |
|
| 10MG | ¥2649 | 有现货 |
|
| 25MG | ¥4981 | 有现货 |
|
| 50MG | ¥6975 | 有现货 |
|
| 100MG | ¥9333 | 有现货 |
|
| 500MG | ¥18743 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BNTA
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BNTA 是一种有效的细胞外基质 (ECM) 调节剂,通过激活超氧化物歧化酶 3 (SOD3) 促进软骨细胞上软骨结构分子的合成。BNTA 通过调节软骨生成显示了一种有希望的缓解骨关节炎的潜力。
-
产品描述BNTA, a potent extracellular matrix (ECM) modulator, facilitates cartilage structural molecule synthesis on chondrocytes by activating superoxide dismutase 3 (SOD3). BNTA shows a promising potential for osteoarthritis alleviation by modulating cartilage generation.
-
体外实验BNTA (0.01-10?μM; 1-7 d) does not decrease cell viability of human osteoarthritis chondrocytes and rat primary chondrocytes.BNTA (0.1 μM; 2 d) increases SOX9 protein markedly.BNTA (0.1 μM; 2 d) remarkably increases the COL2A1 and SOX9 protein levels in IL1β-induced rat OA chondrocytes.BNTA (10 μM; 5 d) increases proteoglycan staining in ATDC5 cells.BNTA (0.01-10?μM; 6 h) upregulates the expression levels of ECM-related genes COL2A1, ACAN, proteoglycan 4 (PRG4), and SRY-box 9 (SOX9) in human OA chondrocytes.BNTA (0.01-10?μM; 6 h) increases Col2a1, Acan, Prg4, and Sox9 mRNA levels, with maximum effects around 0.1?μM in IL1β-induced rat OA chondrocytes.BNTA (0.01-1?μM; 2 or 3 w) enhances anabolism and inhibited inflammatory response in osteoarthritis cartilage explants.Cell Viability Assay Cell Line:Human OA chondrocytes Concentration:0.01, 0.1, 1, 10 μM Incubation Time:1, 3, 5, 7 d Result:No toxicity was observed.Western Blot Analysis Cell Line:Human OA chondrocytes Concentration:0.1 μM Incubation Time:2 d Result:Elevated SOX9 protein compared with vehicle.
-
体内实验BNTA (0.015-1.5 mg/kg; intra-articular injection; twice a week for 4 and 8 weeks) could attenuate OA progression developed after anterior cruciate ligament transection (ACLT) in rats.Animal Model:Male SD rats weighing 80?g are induced by ACLT Dosage:0.015, 0.15, 1.5 mg/kg Administration:Intra-articular injection; twice a week for 4 and 8 weeks Result:Attenuated post-traumatic osteoarthritis development after intra-articular injection for 4 and 8 weeks and was well tolerated.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Reactive Oxygen Species
-
研究领域——
-
适应症——
化学信息
-
CAS Number685119-25-9
-
分子量456.76
-
分子式C17H11BrClNO3S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (218.93 mM; 超声助溶 )
-
SMILESClc1ccccc1C(=O)Nc1c(Br)scc1S(=O)(=O)c1ccccc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Shi Y, et, al. A small molecule promotes cartilage extracellular matrix generation and inhibits osteoarthritis development. Nat Commun. 2019 Apr 23; 10(1): 1914.?
产品手册
关联产品
-
L(+)-Ornithine hydro...
L-鸟氨酸盐酸盐通过提高能量消耗效率、促进氨的排泄而具有抗疲劳作用。它是尿素循环中的关键反应物之一。
-
Fulacimstat
Fulacimstat (BAY 1142524, BAY1142524) 是一种有效的口服食糜酶抑制剂,对人和仓鼠食糜酶的 IC50 分别为 4 nM 和 3 nM。
-
Tiadinil
Tiadinil 是一种植物系统获得性抗性激活剂,可促进食草动物诱导的植物挥发物的产生。
021-51111890
购物车()
sales@molnova.cn

